Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Not applicableUnknownNCT03140007
What this trial is testing

Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .

Who this might be right for
CholangiocarcinomaBiliary Stricture
Asian Institute of Gastroenterology, India 60
Testing effectiveness (Phase 2)Looking for participantsNCT06274879
What this trial is testing

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

Who this might be right for
Bile Duct Cancer
Insel Gruppe AG, University Hospital Bern 36
Not applicableLooking for participantsNCT06899854
What this trial is testing

Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Fondazione IRCCS Policlinico San Matteo di Pavia 53
Testing effectiveness (Phase 2)Looking for participantsNCT06860477
What this trial is testing

Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)

Who this might be right for
Intrahepatic Cholangiocellular Carcinoma
Fudan University 92
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Testing effectiveness (Phase 2)Study completedNCT03579771
What this trial is testing

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Who this might be right for
Resectable CholangiocarcinomaStage IB Intrahepatic Cholangiocarcinoma AJCC v8Stage II Intrahepatic Cholangiocarcinoma AJCC v8+3 more
Emory University 30
Not applicableUnknownNCT05706974
What this trial is testing

Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

Who this might be right for
Bile Duct Cancer
Power Life Sciences Inc. 500
Not applicableLooking for participantsNCT07795619
What this trial is testing

HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma

Who this might be right for
IRE
Tianjin Medical University Cancer Institute and Hospital 60
Post-approval studies (Phase 4)Study completedNCT01256047
What this trial is testing

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Who this might be right for
Bile Duct Cancer
Chiba University 40
Large-scale testing (Phase 3)Looking for participantsNCT07221253
What this trial is testing

Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 1,100
Early research (Phase 1)Study completedNCT00475956
What this trial is testing

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
AstraZeneca 40
Not applicableUnknownNCT05626127
What this trial is testing

MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Who this might be right for
Hilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Not applicableWithdrawnNCT02872831
What this trial is testing

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Who this might be right for
Pancreatic CancerLymphadenopathyCholangiocarcinoma
Thomas Jefferson University
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT03377179
What this trial is testing

ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited 65
Not applicableLooking for participantsNCT06849180
What this trial is testing

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaCombined Hepatocellular Carcinoma and CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Zhongda Hospital 198
Next Page